Cannabidiol exerts protective effects in an in vitro model of Parkinson's disease activating AKT/mTOR pathway
A Gugliandolo, F Pollastro, P Bramanti, E Mazzon - Fitoterapia, 2020 - Elsevier
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the
degeneration of the nigrostriatal dopaminergic pathway with loss of substantia nigra pars …
degeneration of the nigrostriatal dopaminergic pathway with loss of substantia nigra pars …
Cannabidiol exerts protective effects in an in vitro model of Parkinson's disease activating AKT/mTOR pathway.
A Gugliandolo, F Pollastro, P Bramanti, E Mazzon - Fitoterapia, 2020 - europepmc.org
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the
degeneration of the nigrostriatal dopaminergic pathway with loss of substantia nigra pars …
degeneration of the nigrostriatal dopaminergic pathway with loss of substantia nigra pars …
Cannabidiol exerts protective effects in an in vitro model of Parkinson's disease activating AKT/mTOR pathway
A Gugliandolo, F Pollastro, P Bramanti… - …, 2020 - pubmed.ncbi.nlm.nih.gov
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the
degeneration of the nigrostriatal dopaminergic pathway with loss of substantia nigra pars …
degeneration of the nigrostriatal dopaminergic pathway with loss of substantia nigra pars …
Cannabidiol exerts protective effects in an in vitro model of Parkinson's disease activating AKT/mTOR pathway.
A Gugliandolo, F Pollastro, P Bramanti, E Mazzon - 2020 - cabidigitallibrary.org
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the
degeneration of the nigrostriatal dopaminergic pathway with loss of substantia nigra pars …
degeneration of the nigrostriatal dopaminergic pathway with loss of substantia nigra pars …
Cannabidiol exerts protective effects in an in vitro model of Parkinson's disease activating AKT/mTOR pathway
A Gugliandolo, F Pollastro, P Bramanti, E Mazzon - …, 2020 - iris.uniecampus.it
: Parkinson's disease (PD) is a neurodegenerative disorder characterized by the
degeneration of the nigrostriatal dopaminergic pathway with loss of substantia nigra pars …
degeneration of the nigrostriatal dopaminergic pathway with loss of substantia nigra pars …
Cannabidiol exerts protective effects in an in vitro model of Parkinson's disease activating AKT/mTOR pathway
A Gugliandolo, F Pollastro, P Bramanti, E Mazzon - FITOTERAPIA, 2020 - iris.uniupo.it
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the
degeneration of the nigrostriatal dopaminergic pathway with loss of substantia nigra pars …
degeneration of the nigrostriatal dopaminergic pathway with loss of substantia nigra pars …
Cannabidiol exerts protective effects in an in vitro model of Parkinson's disease activating AKT/mTOR pathway
A Gugliandolo, F Pollastro, P Bramanti, E Mazzon - Fitoterapia, 2020 - research.uniupo.it
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the
degeneration of the nigrostriatal dopaminergic pathway with loss of substantia nigra pars …
degeneration of the nigrostriatal dopaminergic pathway with loss of substantia nigra pars …
Cannabidiol exerts protective effects in an in vitro model of Parkinson's disease activating AKT/mTOR pathway
A Gugliandolo, F Pollastro, P Bramanti, E Mazzon - Fitoterapia, 2020 - research.uniupo.it
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the
degeneration of the nigrostriatal dopaminergic pathway with loss of substantia nigra pars …
degeneration of the nigrostriatal dopaminergic pathway with loss of substantia nigra pars …